Premium
THE REAL‐WORLD EFFICACY OF FIRST‐LINE TYROSINE KINASE INHIBITORS IN ASIAN PATIENTS WITH EGFR MUTATION NON‐SMALL CELL LUNG CANCER
Publication year - 2018
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13419_46
Subject(s) - medicine , lung cancer , tyrosine kinase , mutation , cancer research , tyrosine kinase inhibitor , oncology , cancer , gene , genetics , receptor , biology